跳至主要内容
临床试验/NCT03437161
NCT03437161已完成不适用

A Prospective Trial to Compare Deep Inspiratory Breath Hold (DIBH) With Prone Breast Irradiation

NYU Langone Health0 个研究点目标入组 40 人开始时间: 2017年1月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
主要终点
Mean cardiac dose

研究概览

简要总结

This phase II trial studies how well deep inspiratory breath hold or prone breast radiation therapy works in reducing cardiac dose in patients with breast cancer or ductal carcinoma in situ. Deep inspiratory breath hold is a technique that involves a patient holding their breath during radiation to move the heart away from the breast to minimize radiation to the heart. Prone breast radiation therapy is a technique in which a patient receives treatment "face-down" to minimize the radiation to the rest of the body, including the heart and lungs. Comparing deep inspiratory breath hold to prone breast radiation therapy may help doctors improve radiation to the target while reducing radiation to healthy tissues surrounding the target.

详细描述

Patients attend a simulation visit and undergo two CT scans, one in the prone position and one in the supine position with DIBH. Within 1 week after the simulation visit, patients undergo radiation therapy either in the supine position with DIBH or in the prone position daily for 15-30 consecutive days as per physician's prescription

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Any woman with biopsy proven left breast DCIS or invasive cancer who has undergone a lumpectomy and who requires whole breast irradiation to the breast alone (and not to any nodal regions) as per the treating radiation oncologist

排除标准

  • Previous radiation to the ipsilateral breast
  • All pre-menopausal women will require a urine qualitative pregnancy test to exclude pregnancy; pregnant women will be excluded from the study

结局指标

主要结局

Mean cardiac dose

时间窗: Up to 6 weeks

Assess whether the mean cardiac dose in the supine DIBH plan differs from the mean cardiac dose in the prone plan within strata defined by total RT dose.

次要结局

  • Mean left anterior descending artery (LAD) dose in DIBH plan vs. prone plan(Up to 6 weeks)
  • Maximum left anterior descending artery (LAD) dose in DIBH plan vs. prone plan(Up to 6 weeks)
  • Volume of ipsilateral lung receiving > 20Gy(Up to 6 weeks)
  • Volume of the contralateral breast receiving > 5 Gy(Up to 6 weeks)
  • Maximum point dose to planning target volume (PTV) breast(Up to 6 weeks)
  • Change in distance between the chest wall and heart (at the most lateral portion of the chest-wall-heart interface)(Up to 6 weeks)
  • Patient treatment plan (supine with DIBH or prone)(Up to 6 weeks)
  • Distance from the mid-sternum to the nipple when the patient is in the prone position(Up to 6 weeks)
  • PTV breast volume as calculated on the prone scan(Up to 6 weeks)
  • Volume of heart receiving > 20 gray (Gy)(Up to 6 weeks)
  • Maximum separation(Up to 6 weeks)
  • Mean ipsilateral lung dose(Up to 6 weeks)

研究者

申办方类型
Other
责任方
Sponsor

相似试验